HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jana Karasova Selected Research

asoxime chloride (H16)

1/2009An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
12/2008A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice.
9/2008A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
11/2007The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
1/2007A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
1/2007A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jana Karasova Research Topics

Disease

13Poisoning
01/2010 - 01/2007

Drug/Important Bio-Agent (IBA)

12OximesIBA
08/2009 - 01/2007
10tabunIBA
01/2010 - 01/2007
6asoxime chloride (H16)IBA
01/2009 - 01/2007
5Obidoxime Chloride (Obidoxime)IBA
01/2009 - 01/2007
4Trimedoxime (Trimedoxime Bromide)IBA
12/2008 - 09/2007
3cyclohexyl methylphosphonofluoridate (cyclosarin)IBA
01/2009 - 11/2007
3AtropineFDA LinkGeneric
01/2009 - 01/2007
2AntidotesIBA
01/2010 - 09/2007
2Neuroprotective AgentsIBA
01/2009 - 01/2007
2SomanIBA
09/2008 - 01/2007
2AcetylcholinesteraseIBA
01/2008 - 01/2007